A groundbreaking stem cell therapy offers new hope for type 1 diabetes, with early results showing potential for insulin ...
GlobalData on MSN6d
FDA breakthrough status for Bluejay’s CHD therapy brelovitugThe US Food and Drug Administration (FDA) has granted breakthrough therapy designation to Bluejay Therapeutics’ fully human ...
CAYMAN ISLANDS - Silexion Therapeutics Corp. (NASDAQ: SLXN), a biotech firm focusing on RNA interference (RNAi) treatments, ...
The Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to brelovitug (BJT-778) for the treatment of chronic hepatitis delta (CHD).
Innovent Biologics, Inc., announced that the Center for Drug Evaluation (CDE) of China's National Medical Products ...
Eleven drugs are poised to reach blockbuster status, dramatically improving patient outcomes on a global scale.
As hair thinning and skin aging continue to be prevalent concerns worldwide, VCare's latest GFC treatment has emerged as a ...
What You Need to Know The global hydrogen water market is projected to grow from USD 2.5 billion in 2024 to USD 4.35 billion ...
JW Therapeutics (HKEx: 2126), an independent and innovative biotechnology company focused on developing, manufacturing and commercializing cell immunotherapy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback